Yumanity Therapeutics Revenue, Growth & Competitor Profile

DBA PROTEOSTASIS THERAPEUTICS, INC.

Company Profile & Annual Report for Yumanity Therapeutics

Access the complete profile.

Yumanity Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	40 Guest St Ste 4410 Boston, MA 02135

Note: Revenues for privately held companies are statistical evaluations.


Yumanity Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Yumanity Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Yumanity Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Yumanity Therapeutics Annual Revenue and Growth Rate

Yumanity Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Yumanity Therapeutics's revenues are gauged from an analysis of company filings.

Yumanity Therapeutics's Income Statement (based on Industry Averages)

Yumanity Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Yumanity Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 20, 2023	1	0%	$3 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Yumanity Therapeutics is developing and marketing. Yumanity Therapeutics doesn't have any recent trademark applications, indicating Yumanity Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
#CFORWARD Providing online educational information relating to cystic fibrosis, namely, providing education courses in the field of cystic fibrosis offered through online, non-downloadable videos; providing a website featuring non-downloadable videos on the subject of cystic fibrosis; Providing an interactive website featuring information and links related to cystic fibrosis and the options for diagnosis and treatment	04/09/2019
YUMANITY Pharmaceutical preparations for the treatment of neurodegenerative diseases	05/16/2017
PTI PROTEOSTASIS THERAPEUTICS, INC. Pharmaceutical preparations for the treatment of respiratory conditions, diseases, syndromes and disorders	08/31/2015

See all trademarks and details in the Full Report.

Market Share of Yumanity Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Yumanity Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Yumanity Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Other Companies at 40 Guest St, Boston MA

Company	Headquarters	Revenue ($ MM)
NEXTRNA THERAPEUTICS	Boston, MA	100
SENSORIUM THERAPEUTICS	Boston, MA	29

Future Competition: Yumanity Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Yumanity Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)